Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günter Schlimok

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
World Journal of Clinical Oncology|December 24, 2016
Circulating cytokeratin-positive cells and tumor budding in colorectal cancerBruno Märkl, Narjes Wilhelms, Matthias Anthuber, et al.
Plos One|January 28, 2014
Reliable single cell array CGH for clinical samplesZbigniew T Czyż, Martin Hoffmann, Günter Schlimok, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapyStephan Braun, Florian D Vogl, Wolfgang Janni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Cardiac involvement in malignancies. Case 4. Primary cardiac diffuse large B-cell lymphoma: diagnosis by transesophageal echocardiography-guided transvenous biopsyBernd Oliver Maier, Wolfgang von Scheidt, Joachim Sciuk, et al.
BMC Cancer|July 17, 2019
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancerBruno Märkl, Martin Kazik, Nadia Harbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancerDorothea Weckermann, Bernhard Polzer, Thomas Ragg, et al.
Blood|December 31, 2005
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphomaBertram Glass, Marita Kloess, Martin Bentz, et al.
Oncology Research and Treatment|October 7, 2016
Consultation Program for Patients with Cancer-Related Fatigue: A Systematic Evaluation of the Experiences of the Bavarian Cancer SocietyIrene Fischer, Carola Riedner, Peter Bojko, et al.
Nature Biotechnology|March 30, 2002
Combined transcriptome and genome analysis of single micrometastatic cellsChristoph A Klein, Stefan Seidl, Karina Petat-Dutter, et al.
Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
World Journal of Clinical Oncology|December 24, 2016
Circulating cytokeratin-positive cells and tumor budding in colorectal cancerBruno Märkl, Narjes Wilhelms, Matthias Anthuber, et al.
Plos One|January 28, 2014
Reliable single cell array CGH for clinical samplesZbigniew T Czyż, Martin Hoffmann, Günter Schlimok, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapyStephan Braun, Florian D Vogl, Wolfgang Janni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Cardiac involvement in malignancies. Case 4. Primary cardiac diffuse large B-cell lymphoma: diagnosis by transesophageal echocardiography-guided transvenous biopsyBernd Oliver Maier, Wolfgang von Scheidt, Joachim Sciuk, et al.
BMC Cancer|July 17, 2019
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancerBruno Märkl, Martin Kazik, Nadia Harbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancerDorothea Weckermann, Bernhard Polzer, Thomas Ragg, et al.
Blood|December 31, 2005
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphomaBertram Glass, Marita Kloess, Martin Bentz, et al.
Oncology Research and Treatment|October 7, 2016
Consultation Program for Patients with Cancer-Related Fatigue: A Systematic Evaluation of the Experiences of the Bavarian Cancer SocietyIrene Fischer, Carola Riedner, Peter Bojko, et al.
Nature Biotechnology|March 30, 2002
Combined transcriptome and genome analysis of single micrometastatic cellsChristoph A Klein, Stefan Seidl, Karina Petat-Dutter, et al.
Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.
Pageof 3